19 research outputs found

    Doxycycline in autoimmune central nervous system disorders in children: an in vitro study

    No full text
    Tetracyclines have antiinflammatory properties. To test the in vitro effect of doxycycline in autoimmune neurological disorders of childhood, peripheral blood lymphocytes from multiple sclerosis (n=11), acute disseminated encephalomyelitis (n=12), and control patients (epilepsy and headache, n=12), all aged 5-17, were examined for proliferation, migration, and apoptosis after culture with doxycycline, concanavalin A and myelin basic protein for 48 hours. Doxycycline increased proliferation in the control group, and less in the multiple sclerosis group but not in the acute disseminated encephalomyelitis group (p < 0.03). It increased apoptosis in multiple sclerosis patients (p < 0.02). According to this preliminary study, doxycycline might have immunomodulatory effects in children, justifying future studies with larger and more homogeneous patient groups

    Doxycycline in autoimmune central nervous system disorders in children: an in vitro study

    No full text
    Tetracyclines have antiinflammatory properties. To test the in vitro effect of doxycycline in autoimmune neurological disorders of childhood, peripheral blood lymphocytes from multiple sclerosis (n=11), acute disseminated encephalomyelitis (n=12), and control patients (epilepsy and headache, n=12), all aged 5-17, were examined for proliferation, migration, and apoptosis after culture with doxycycline, concanavalin A and myelin basic protein for 48 hours. Doxycycline increased proliferation in the control group, and less in the multiple sclerosis group but not in the acute disseminated encephalomyelitis group (

    Response to Dr Anlar

    No full text

    A Case of Early Infantile Epileptic Encephalopathy Due to KCNQ2 Gene Mutation Presenting With Episodes of Hiccups

    No full text
    Neonatal epilepsy syndromes are responsible for only 15% of the cases of neonatal seizure. An underlying genetic disorder can be detected in approximately 42% of this subgroup. KCNQ2 gene-associated epilepsies are very rare and more common presentations are self-limited familial neonatal epilepsy (SLFNE) and early infantile epileptic encephalopathies (EIEE). The most common initial seizure semiologies are tonic seizures with or without autonomic symptoms in EIEE resulting from KCNQ2 gene mutation. It is characterized by early neonatal onset seizures with suppression burst pattern on electroencephalogram and typically results in severe developmental delay. Therapeutic options for infants with KCNQ2-related EIEE are limited and there is no consensus about it in the literature. Herein, the neonate with EIEE with unexpected episodes of hiccups due to novel mutation of the KCNQ2 gene, which was reported second time, was presented and antiepileptic treatment strategies were discussed in the light of current literature

    Diagnostic criteria of pediatric migraine without aura

    No full text
    The objectives of this study were to assess the validity of the International Classification of Headache Disorders-I (ICHD-I) and the International Headache Society-Revised (IHS-R) criteria and to evaluate the other headache features that are not included in these criteria for migraine without aura in the pediatric population. One hundred and thirty-two children who referred to our clinic with the complaint of chronic or recurrent headache were evaluated. Clinical diagnosis of the pediatric neurologist was used as the gold standard in evaluating the validity of ICHD-I and IHS-R criteria and the other headache features. After eliminating patients with other migraine types, secondary headache, and missing data, 92 patients were included in the study according to their records. Sixty-one children (66.3%) were diagnosed as migraine without aura. Using the clinical diagnosis as the gold standard, the specificity of ICHD-I criteria was detected as 93.5%, while the sensitivity was detected as 36.1%. IHS-R criteria had 90.3% specificity and 78.7% sensitivity. Relief of headache with sleeping or lying down in a dark, quiet room was found to be the highest specific and sensitive factor of the other headache features not included in these criteria. IHS-R criteria were found to be more valid in the diagnosis of migraine without aura than ICHD-I criteria. IHS-R criteria are recommended both in clinical practice and in the studies requiring migraine without aura case definitions in the pediatric population

    A rare cause of mental motor retardation: recessive congenital methemoglobinemia type II

    No full text
    Recessive congenital methemoglobinemia (RCM) is a very rare disorder caused by NADH- cytochrome b5 reductase (cytb5r) deficiency. It has been classified into four types. Type I presents with mild cyanosis due to a significant deficiency of cytb5r in erythrocytes only. In type II, the deficiency occurs in all tissues and causes growth and mental retardation and other neurological impairments. RCM types I and II are caused by a defect in a single gene, which is located on chromosome 22 (locus DIA 1: q 13.31-qter). Prenatal diagnosis is possible. Cyanosis can be well treated by 200-500 mg of ascorbic acid daily; there is no effective therapy for the progressive neurological impairments. This report presents two siblings with central cyanosis, growth retardation, mental retardation, microcephaly, dystonia and hypertonia diagnosed as RCM type II
    corecore